Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Arformoterol Tartrate

The tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract Objective: This retrospective cohort study compared exacerbations, health services utilization, and costs among chronic… Expand
2014
2014
BACKGROUND: Arformoterol tartrate (arformoterol, 15 μg bid) is a nebulized long-acting β2-agonist approved for maintenance… Expand
  • figure 1
  • figure 2
  • table 1
  • table 1
  • figure 3
2013
2013
Background Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Review
2013
Review
2013
Chronic obstructive pulmonary disease (COPD) is a serious global health burden. Comprehensive management of COPD includes both… Expand
  • figure 1
  • figure 2
  • table 1
Review
2010
Review
2010
Some basic scientific data suggest that (S)-enantiomers of β2-agonists have different and sometimes opposing effects to (R… Expand
2008
2008
BACKGROUND Arformoterol is a single-isomer (R,R-formoterol) nebulized long-acting beta(2)-agonist approved for use in patients… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2007
Highly Cited
2007
OBJECTIVE The aim of this study was to assess the efficacy and tolerability of nebulized arformoterol tartrate (a selective, long… Expand
2007
2007
ABSTRACT Objective: Arformoterol tartrate inhalation solution (15 μg/2 mL) is approved for the twice-daily, long-term maintenance… Expand
2006
2006
β 2 -Adrenoceptor agonists are widely used as adjuncts to corticosteroids for the treatment of chronic obstructive pulmonary… Expand
Review
2004
Review
2004
  • Drugs in R&D
  • 2004
  • Corpus ID: 6119930
Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist… Expand